Cargando…
Biocompatibility of single-walled carbon nanotube composites for bone regeneration
OBJECTIVES: The purpose of this study was to evaluate in vivo biocompatibility of novel single-walled carbon nanotubes (SWCNT)/poly(lactic-co-glycolic acid) (PLAGA) composites for applications in bone and tissue regeneration. METHODS: A total of 60 Sprague-Dawley rats (125 g to 149 g) were implanted...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
British Editorial Society of Bone and Joint Surgery
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4438669/ https://www.ncbi.nlm.nih.gov/pubmed/25943595 http://dx.doi.org/10.1302/2046-3758.45.2000382 |
_version_ | 1782372379703377920 |
---|---|
author | Gupta, A. Liberati, T. A. Verhulst, S. J. Main, B. J. Roberts, M. H. Potty, A. G. R. Pylawka, T. K. El-Amin III, S. F. |
author_facet | Gupta, A. Liberati, T. A. Verhulst, S. J. Main, B. J. Roberts, M. H. Potty, A. G. R. Pylawka, T. K. El-Amin III, S. F. |
author_sort | Gupta, A. |
collection | PubMed |
description | OBJECTIVES: The purpose of this study was to evaluate in vivo biocompatibility of novel single-walled carbon nanotubes (SWCNT)/poly(lactic-co-glycolic acid) (PLAGA) composites for applications in bone and tissue regeneration. METHODS: A total of 60 Sprague-Dawley rats (125 g to 149 g) were implanted subcutaneously with SWCNT/PLAGA composites (10 mg SWCNT and 1gm PLAGA 12 mm diameter two-dimensional disks), and at two, four, eight and 12 weeks post-implantation were compared with control (Sham) and PLAGA (five rats per group/point in time). Rats were observed for signs of morbidity, overt toxicity, weight gain and food consumption, while haematology, urinalysis and histopathology were completed when the animals were killed. RESULTS: No mortality and clinical signs were observed. All groups showed consistent weight gain, and the rate of gain for each group was similar. All groups exhibited a similar pattern for food consumption. No difference in urinalysis, haematology, and absolute and relative organ weight was observed. A mild to moderate increase in the summary toxicity (sumtox) score was observed for PLAGA and SWCNT/PLAGA implanted animals, whereas the control animals did not show any response. Both PLAGA and SWCNT/PLAGA showed a significantly higher sumtox score compared with the control group at all time intervals. However, there was no significant difference between PLAGA and SWCNT/PLAGA groups. CONCLUSIONS: Our results demonstrate that SWCNT/PLAGA composites exhibited in vivo biocompatibility similar to the Food and Drug Administration approved biocompatible polymer, PLAGA, over a period of 12 weeks. These results showed potential of SWCNT/PLAGA composites for bone regeneration as the low percentage of SWCNT did not elicit a localised or general overt toxicity. Following the 12-week exposure, the material was considered to have an acceptable biocompatibility to warrant further long-term and more invasive in vivo studies. Cite this article: Bone Joint Res 2015;4:70–7 |
format | Online Article Text |
id | pubmed-4438669 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | British Editorial Society of Bone and Joint Surgery |
record_format | MEDLINE/PubMed |
spelling | pubmed-44386692015-05-26 Biocompatibility of single-walled carbon nanotube composites for bone regeneration Gupta, A. Liberati, T. A. Verhulst, S. J. Main, B. J. Roberts, M. H. Potty, A. G. R. Pylawka, T. K. El-Amin III, S. F. Bone Joint Res General Orthopaedics OBJECTIVES: The purpose of this study was to evaluate in vivo biocompatibility of novel single-walled carbon nanotubes (SWCNT)/poly(lactic-co-glycolic acid) (PLAGA) composites for applications in bone and tissue regeneration. METHODS: A total of 60 Sprague-Dawley rats (125 g to 149 g) were implanted subcutaneously with SWCNT/PLAGA composites (10 mg SWCNT and 1gm PLAGA 12 mm diameter two-dimensional disks), and at two, four, eight and 12 weeks post-implantation were compared with control (Sham) and PLAGA (five rats per group/point in time). Rats were observed for signs of morbidity, overt toxicity, weight gain and food consumption, while haematology, urinalysis and histopathology were completed when the animals were killed. RESULTS: No mortality and clinical signs were observed. All groups showed consistent weight gain, and the rate of gain for each group was similar. All groups exhibited a similar pattern for food consumption. No difference in urinalysis, haematology, and absolute and relative organ weight was observed. A mild to moderate increase in the summary toxicity (sumtox) score was observed for PLAGA and SWCNT/PLAGA implanted animals, whereas the control animals did not show any response. Both PLAGA and SWCNT/PLAGA showed a significantly higher sumtox score compared with the control group at all time intervals. However, there was no significant difference between PLAGA and SWCNT/PLAGA groups. CONCLUSIONS: Our results demonstrate that SWCNT/PLAGA composites exhibited in vivo biocompatibility similar to the Food and Drug Administration approved biocompatible polymer, PLAGA, over a period of 12 weeks. These results showed potential of SWCNT/PLAGA composites for bone regeneration as the low percentage of SWCNT did not elicit a localised or general overt toxicity. Following the 12-week exposure, the material was considered to have an acceptable biocompatibility to warrant further long-term and more invasive in vivo studies. Cite this article: Bone Joint Res 2015;4:70–7 British Editorial Society of Bone and Joint Surgery 2015-05-01 /pmc/articles/PMC4438669/ /pubmed/25943595 http://dx.doi.org/10.1302/2046-3758.45.2000382 Text en ©2015 The British Editorial Society of Bone & Joint Surgery ©2015 The British Editorial Society of Bone & Joint Surgery. This is an open-access article distributed under the terms of the Creative Commons Attributions licence, which permits unrestricted use, distribution, and reproduction in any medium, but not for commercial gain, provided the original author and source are credited. |
spellingShingle | General Orthopaedics Gupta, A. Liberati, T. A. Verhulst, S. J. Main, B. J. Roberts, M. H. Potty, A. G. R. Pylawka, T. K. El-Amin III, S. F. Biocompatibility of single-walled carbon nanotube composites for bone regeneration |
title | Biocompatibility of single-walled carbon nanotube composites for bone regeneration |
title_full | Biocompatibility of single-walled carbon nanotube composites for bone regeneration |
title_fullStr | Biocompatibility of single-walled carbon nanotube composites for bone regeneration |
title_full_unstemmed | Biocompatibility of single-walled carbon nanotube composites for bone regeneration |
title_short | Biocompatibility of single-walled carbon nanotube composites for bone regeneration |
title_sort | biocompatibility of single-walled carbon nanotube composites for bone regeneration |
topic | General Orthopaedics |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4438669/ https://www.ncbi.nlm.nih.gov/pubmed/25943595 http://dx.doi.org/10.1302/2046-3758.45.2000382 |
work_keys_str_mv | AT guptaa biocompatibilityofsinglewalledcarbonnanotubecompositesforboneregeneration AT liberatita biocompatibilityofsinglewalledcarbonnanotubecompositesforboneregeneration AT verhulstsj biocompatibilityofsinglewalledcarbonnanotubecompositesforboneregeneration AT mainbj biocompatibilityofsinglewalledcarbonnanotubecompositesforboneregeneration AT robertsmh biocompatibilityofsinglewalledcarbonnanotubecompositesforboneregeneration AT pottyagr biocompatibilityofsinglewalledcarbonnanotubecompositesforboneregeneration AT pylawkatk biocompatibilityofsinglewalledcarbonnanotubecompositesforboneregeneration AT elaminiiisf biocompatibilityofsinglewalledcarbonnanotubecompositesforboneregeneration |